On
Monday, November 9, 2009, the Supreme Court will hear oral argument in In re Bilski, and two CLE
providers plan to offer same day or next day coverage of the proceedings.

Practising
Law Institute (PLI) will be offering same day coverage on its Patent Practice
Center blog.  Gene Quinn, the editor of the Patent
Practice Center blog and founder of IPWatchdog, Inc., and John White, the Director
of PLI Patent Professional Development and a patent attorney with Berenato,
White & Stavish, LLC, will be filing reports throughout the day.

PLI
will also offer an audio briefing entitled: "Bilski Supreme Court Arguments: Eyewitness Report and Expert
Analysis " on Wednesday, November 11, 2009, from 1:00-2:00 PM (EST).  For the audio briefing, Gene Quinn and
John White will be joined by Scott Alter of Faegre & Benson LLP and Douglas
Nemec of Skadden, Arps, Slate, Meagher & Flom LLP.  The registration fee for the audio
webcast is $299.  Those interested
in registering for the webcast can do so here.

The
Intellectual Property Owners Association (IPO) will offer a one-hour webinar
entitled: "The 'Day After' Show: Analyzing the Bilski Oral Arguments at
the U.S. Supreme Court" on Tuesday, November 10, 2009 beginning at 2:00 PM
(EST).  The IPO webinar will
provide the views of three eyewitnesses to the proceedings:  David Ball, Jr., a partner at Weil,
Gotshal & Manges LLP; Mark Perry, a litigation partner at Gibson, Dunn
& Crutcher LLP who co-authored an amicus
brief on behalf of Microsoft Corporation, Koninklijke Philips Electronics N.V.,
and Symantec Corporation in support of Kappos; and Wayne Sobon, Associate
General Counsel and Director of Intellectual Property for Accenture, which filed
multiple amicus briefs in support of
Bilski.  The speakers will discuss what
to do about existing patents, pending applications, and claims drafting for
inventions likely to be affected by the Bilski
ruling.  The registration fee for
the webinar is $100.  Those
interested in registering for the webinar can do so here.

For
additional information regarding the Bilski
decision and its impact on biotech subject matter, please see:
•
"BIO Files Amicus Brief in Bilski," August 13, 2009
•
"The Supreme Court, In re Bilski and the Lingering Question of LabCorp v.
Metabolite," June 1, 2009
•
"Applying In re Bilski to Diagnostic Method Claims," February 5, 2009
•
"The Relevance of In re Bilski to the Patentability of the Metabolite
Claim," November 17, 2008